983 related articles for article (PubMed ID: 30451675)
1. [The CRISPR-Cas system: beyond genome editing].
Croteau FR; Rousseau GM; Moineau S
Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic and diagnostic relevance of Crispr technology.
El Ouar I; Djekoun A
Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
Salsman J; Masson JY; Orthwein A; Dellaire G
Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
[TBL] [Abstract][Full Text] [Related]
4. CRISPR: History and perspectives to the future.
Kozovska Z; Rajcaniova S; Munteanu P; Dzacovska S; Demkova L
Biomed Pharmacother; 2021 Sep; 141():111917. PubMed ID: 34328110
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
6. Application of different types of CRISPR/Cas-based systems in bacteria.
Liu Z; Dong H; Cui Y; Cong L; Zhang D
Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
[TBL] [Abstract][Full Text] [Related]
7. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
8. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
Mojica FJM; Montoliu L
Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
[TBL] [Abstract][Full Text] [Related]
10. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
11. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
Guitart JR; Johnson JL; Chien WW
J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering.
Singh A; Chakraborty D; Maiti S
Chem Soc Rev; 2016 Dec; 45(24):6666-6684. PubMed ID: 27711765
[TBL] [Abstract][Full Text] [Related]
13. [CRISPR-Cas system as molecular scissors for gene therapy].
Heinz GA; Mashreghi MF
Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
Kuruvilla J; Sasmita AO; Ling APK
Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
[TBL] [Abstract][Full Text] [Related]
15. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
[TBL] [Abstract][Full Text] [Related]
16. [Application of CRISPR/Cas9 mediated genome editing in farm animals].
Xing YY; Yang Q; Ren J
Yi Chuan; 2016 Mar; 38(3):217-26. PubMed ID: 27001476
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
Zhang X; Wang L; Liu M; Li D
Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
19. The genome editing revolution: A CRISPR-Cas TALE off-target story.
Stella S; Montoya G
Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
[TBL] [Abstract][Full Text] [Related]
20. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]